CD19 and lymphoma: Incorporation of CD19 or CD20 for normal B cells and CyIgKappa or CyIgLambda for light-chain monoclonality would enable higher precision and accuracy in detecting ultra-rare single cells driving the initiation and progression of lymphoid cancers.